These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11511764)

  • 1. Behçet's disease in UK children: clinical features and treatment including thalidomide.
    Kari JA; Shah V; Dillon MJ
    Rheumatology (Oxford); 2001 Aug; 40(8):933-8. PubMed ID: 11511764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical experience with thalidomide in the management of severe oral and genital ulceration in conditions such as Behçet's disease: use of neurophysiological studies to detect thalidomide neuropathy.
    Gardner-Medwin JM; Smith NJ; Powell RJ
    Ann Rheum Dis; 1994 Dec; 53(12):828-32. PubMed ID: 7864692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Apremilast for Aphthous Ulcers in a Patient With Behçet’s Syndrome.
    Saini A; Ferguson C; Salkey K
    J Drugs Dermatol; 2018 Dec; 17(12):1328-1329. PubMed ID: 30586267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNF-alpha antagonists and thalidomide for the management of gastrointestinal Behçet's syndrome refractory to the conventional treatment modalities: a case series and review of the literature.
    Hatemi I; Hatemi G; Pamuk ON; Erzin Y; Celik AF
    Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S129-37. PubMed ID: 26486925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trial of Apremilast for Oral Ulcers in Behçet's Syndrome.
    Hatemi G; Mahr A; Ishigatsubo Y; Song YW; Takeno M; Kim D; Melikoğlu M; Cheng S; McCue S; Paris M; Chen M; Yazici Y
    N Engl J Med; 2019 Nov; 381(20):1918-1928. PubMed ID: 31722152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paediatric Behçet's disease: a UK tertiary centre experience.
    Nanthapisal S; Klein NJ; Ambrose N; Eleftheriou D; Brogan PA
    Clin Rheumatol; 2016 Oct; 35(10):2509-16. PubMed ID: 26833394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apremilast for Behçet's syndrome--a phase 2, placebo-controlled study.
    Hatemi G; Melikoglu M; Tunc R; Korkmaz C; Turgut Ozturk B; Mat C; Merkel PA; Calamia KT; Liu Z; Pineda L; Stevens RM; Yazici H; Yazici Y
    N Engl J Med; 2015 Apr; 372(16):1510-8. PubMed ID: 25875256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positioning of apremilast in treatment of Behçet's disease.
    Takeno M
    Mod Rheumatol; 2020 Mar; 30(2):219-224. PubMed ID: 31747804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy of infliximab and thalidomide for refractory entero-Behcet's disease: a case report.
    Li Y; Han Z; Wang X; Mo Z; Zhang W; Li A; Liu S
    BMC Gastroenterol; 2013 Dec; 13():167. PubMed ID: 24321021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thalidomide responsiveness in an infant with Behçet's syndrome.
    Shek LP; Lee YS; Lee BW; Lehman TJ
    Pediatrics; 1999 Jun; 103(6 Pt 1):1295-7. PubMed ID: 10353947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of recurrent perforating intestinal ulcers with thalidomide in Behçet's disease.
    Sayarlioglu M; Kotan MC; Topcu N; Bayram I; Arslanturk H; Gul A
    Ann Pharmacother; 2004 May; 38(5):808-11. PubMed ID: 15010523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Behcet's disease therapy review].
    Vidaller Palacín A; Robert Olalla J; Sanuy Jiménez B; Rufi Rigau G; Folch Civit J; Charte González A
    An Med Interna; 2002 Nov; 19(11):594-8. PubMed ID: 12522899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of apremilast for Behçet's syndrome: a real-life single-centre Italian experience.
    De Luca G; Cariddi A; Campochiaro C; Vanni D; Boffini N; Tomelleri A; Cavalli G; Dagna L
    Rheumatology (Oxford); 2020 Jan; 59(1):171-175. PubMed ID: 31280296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of Behçet's disease].
    Comarmond C; Wechsler B; Cacoub P; Saadoun D
    Rev Med Interne; 2014 Feb; 35(2):126-38. PubMed ID: 24438860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel approaches to Behçet's disease.
    Sakane T; Takeno M
    Expert Opin Investig Drugs; 2000 Sep; 9(9):1993-2005. PubMed ID: 11060788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conjunctival ulcers in Behçet's disease.
    Zamir E; Bodaghi B; Tugal-Tutkun I; See RF; Charlotte F; Wang RC; Wechsler B; LeHoang P; Anteby I; Rao NA
    Ophthalmology; 2003 Jun; 110(6):1137-41. PubMed ID: 12799237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of intestinal Behçet's syndrome with chimeric tumour necrosis factor alpha antibody.
    Travis SP; Czajkowski M; McGovern DP; Watson RG; Bell AL
    Gut; 2001 Nov; 49(5):725-8. PubMed ID: 11600479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Behçet's disease--an update.
    Kaklamani VG; Kaklamanis PG
    Semin Arthritis Rheum; 2001 Apr; 30(5):299-312. PubMed ID: 11303303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of colitis in Behçet's disease with thalidomide.
    Postema PT; den Haan P; van Hagen PM; van Blankenstein M
    Eur J Gastroenterol Hepatol; 1996 Sep; 8(9):929-31. PubMed ID: 8889464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A national cohort study on pediatric Behçet's disease: cross-sectional data from an Italian registry.
    Gallizzi R; Pidone C; Cantarini L; Finetti M; Cattalini M; Filocamo G; Insalaco A; Rigante D; Consolini R; Maggio MC; Civino A; Martino S; Olivieri AN; Fabio G; Pastore S; Mauro A; Sutera D; Trimarchi G; Ruperto N; Gattorno M; Cimaz R
    Pediatr Rheumatol Online J; 2017 Dec; 15(1):84. PubMed ID: 29268757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.